查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1790177

細胞和基因療法受託製造廠商市場規模、佔有率和趨勢分析報告：按類型、服務、適應症、方式、地區和細分市場預測，2025 年至 2033 年

Cell & Gene Therapy Contract Research Organizations Market Size, Share & Trends Analysis Report By Type, By Service, By Indication, By Modality, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

全球細胞和基因治療合約開發和受託製造廠商市場摘要

全球細胞和基因治療合約開發和受託製造廠商市場規模預計在 2024 年達到 48.4 億美元，預計在 2033 年將達到 1126 萬美元，2025 年至 2033 年的複合年成長率為 9.89%。這一成長背後的因素包括 CGT 臨床試驗數量的增加、生物技術公司的外包增加、監管複雜性的增加以及全球擴張。

細胞和基因療法受託製造廠商)行業的成長受到臨床管線快速擴張的推動，尤其是在腫瘤學、血液學和罕見遺傳疾病領域。由於 CGT 試驗的高度複雜性、監管審查和成本密集性，越來越多的申辦者轉向 CRO。許多中小型生技公司更傾向於委託，因為這些治療方法需要專業的物流、個人化的生產協調和先進的數據處理能力。此外，全球 ATM臨床實驗申請 (IND) 數量的成長也推動了對監管支援、研究設計和長期安全監測服務的需求。

CRISPR 等基因編輯平台以及病毒和非病毒遞送技術的發展正在改變 CGT 的開發，增加了對專家主導的臨床前和臨床研究支援的需求。提供涵蓋發現、臨床前驗證、載體分析和 GMP 合規性的一體化解決方案的 CRO 正在獲得競爭優勢。此外，資金籌措的增加、策略夥伴關係的加強以及產業整合正在增強 CRO 生態系統隨著創新浪潮而擴展的能力。生態系統的這種轉變使專業的 CRO 成為加速 CGT核准和全球臨床臨床實驗實施的重要合作夥伴。

目錄

第1章調查方法與範圍

第2章執行摘要

3. 細胞和基因治療合約開發和受託製造廠商市場：變數、趨勢和範圍

  • 市場體系展望
  • 細胞和基因治療受託製造廠商市場動態
  • 技術格局
  • 定價模式分析
  • 細胞和基因治療合約開發和受託製造廠商市場分析工具

第4章：細胞和基因治療合約開發和受託製造廠商市場：按類型估計和趨勢分析

  • 細分儀表板
  • 變異分析：依類型
  • 2021 年至 2033 年各類型市場規模與趨勢分析
  • 藥物研發
    • 目標檢驗
    • 先導化合物的鑑定
    • 先導化合物最佳化
  • 臨床前
  • 臨床
    • 第一階段
    • 第二階段
    • 第三階段
    • 第四階段

第5章：細胞和基因治療合約開發和受託製造廠商市場：按服務估算和趨勢分析

  • 細分儀表板
  • 波動分析：按服務
  • 市場規模與趨勢分析：按服務，2021-2033 年
  • 計劃和臨床試驗管理
  • 監理策略
  • 數據管理和醫學寫作
  • 臨床監測
  • 品管/GMP合規性
  • 生物統計學和安全監測
  • 招募病患和設施
  • 技術轉移
  • 其他

第6章細胞和基因治療受託製造廠商市場：按適應症的估計和趨勢分析

  • 細分儀表板
  • 變異分析：按適應症
  • 2021 年至 2033 年按適應症分類的市場規模與趨勢分析
  • 腫瘤學
  • 中樞神經系統疾病
  • 感染疾病
  • 免疫疾病
  • 心血管疾病
  • 呼吸系統疾病
  • 糖尿病
  • 眼科
  • 疼痛管理
  • 其他

第7章細胞和基因治療合約開發和受託製造廠商市場：按方式的估計和趨勢分析

  • 細分儀表板
  • 變異分析：依模態
  • 市場規模與趨勢分析：按方式，2021-2033 年
  • 細胞療法
  • 基因治療
  • 基因改造細胞療法

第 8 章：細胞和基因治療受託製造廠商市場：區域、估計和趨勢分析

  • 市場儀表板
  • 全球市場概況
  • 2021 年至 2033 年各地區市場規模、預測與趨勢分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭態勢

  • 公司分類
  • 細胞和基因治療合約開發和受託製造廠商市場佔有率分析（2024年）
  • 公司簡介
    • Altasciences
    • Allucent
    • Labcorp
    • Linical
    • Medpace
    • Thermo Fisher Scientific Inc.
    • Precision Medicine Group, LLC.
    • QPS Holdings
    • Syneos Health
    • ICON plc
Product Code: GVR-4-68040-672-7

Cell & Gene Therapy Contract Research Organizations Market Summary

The global cell & gene therapy contract research organizations market size was estimated at USD 4.84 billion in 2024 and is projected to reach USD 11.26 million by 2033, growing at a CAGR of 9.89% from 2025 to 2033. The growth is due to the rising clinical trial volume in CGT, increased outsourcing by biotech firms, regulatory complexity, and global expansion, among others.

The growth of the cell & gene therapy contract research organizations industry is fueled by the rapid expansion of clinical pipelines, especially in oncology, hematologic, and rare genetic disorders. Sponsors are increasingly turning to CROs due to the high complexity, regulatory scrutiny, and cost intensity of CGT trials. These therapies demand specialized logistics, personalized manufacturing coordination, and sophisticated data handling capabilities that most small to mid-sized biotech firms prefer to outsource. Moreover, the global increase in Investigational New Drug (IND) applications for ATMPs has heightened demand for regulatory support, trial design, and long-term safety monitoring services.

Advancements in gene-editing platforms such as CRISPR and viral and non-viral delivery technologies are transforming CGT development, thereby intensifying the need for expert-led preclinical and clinical research support. CROs offering integrated solutions across discovery, preclinical validation, vector analytics, and GMP compliance are gaining a competitive edge. Additionally, increased funding, strategic partnerships, and industry consolidation have enhanced the CRO ecosystem's capacity to scale with the innovation surge. This ecosystem shift has positioned specialized CROs as essential partners in accelerating CGT approvals and global trial execution.

Global Cell & Gene Therapy Contract Research Organizations Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global cell & gene therapy contract research organizations market report based on type, service, indication, modality, and region:

  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Drug Discovery
    • Target Validation
    • Lead Identification
    • Lead Optimization
  • Preclinical
  • Clinical
    • Phase I
    • Phase II
    • Phase III
    • Phase IV
  • Service Outlook (Revenue, USD Million, 2021 - 2033)
  • Project & Clinical Trial Management
  • Regulatory Strategy
  • Data Management & Medical Writing
  • Clinical Monitoring
  • Quality Management / GMP Compliance
  • Biostatistics & Safety Monitoring
  • Patient & Site Recruitment
  • Technology Transfer
  • Others
  • Indication Outlook (Revenue, USD Million, 2021 - 2033)
  • Oncology
  • CNS Disorders
  • Infectious Diseases
  • Immunological Disorders
  • Cardiovascular Diseases
  • Respiratory Diseases
  • Diabetes
  • Ophthalmology
  • Pain Management
  • Others
  • Modality Outlook (Revenue, USD Million, 2021 - 2033)
  • Cell-Based Therapies
  • Gene Therapies
  • Gene-Modified Cell Therapies
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Norway
    • Sweden
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Value chain based analysis (Model 2)
    • 1.7.3. Multivariate Analysis (Model 3)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Cell & Gene Therapy Contract Research Organizations Market: Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary Market Outlook
  • 3.2. Cell & Gene Therapy Contract Research Organizations Market Dynamics
    • 3.2.1. Market Driver Impact Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Technological Landscape
  • 3.4. Pricing Model Analysis
  • 3.5. Cell & Gene Therapy Contract Research Organizations Market: Analysis Tools
    • 3.5.1. Porter's Five Forces Analysis
    • 3.5.2. PESTEL Analysis

Chapter 4. Cell & Gene Therapy Contract Research Organizations Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Cell & Gene Therapy Contract Research Organizations Market Type Movement Analysis
  • 4.3. Global Cell & Gene Therapy Contract Research Organizations Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
  • 4.4. Drug Discovery
    • 4.4.1. Drug Discovery Market Estimates and Forecasts, 2021 - 2033 (USD million)
    • 4.4.2. Target Validation
      • 4.4.2.1. Target Validation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.3. Lead Identification
      • 4.4.3.1. Lead Identification Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.4. Lead Optimization
      • 4.4.4.1. Lead Optimization Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Preclinical
    • 4.5.1. Preclinical Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Clinical
    • 4.6.1. Clinical Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.2. Phase I
      • 4.6.2.1. Phase I Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.3. Phase II
      • 4.6.3.1. Phase II Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.4. Phase III
      • 4.6.4.1. Phase III Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.5. Phase IV
      • 4.6.5.1. Phase IV Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Cell & Gene Therapy Contract Research Organizations Market: Service Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Cell & Gene Therapy Contract Research Organizations Market Service Movement Analysis
  • 5.3. Global Cell & Gene Therapy Contract Research Organizations Market Size & Trend Analysis, by Service, 2021 to 2033 (USD Million)
  • 5.4. Project & Clinical Trial Management
    • 5.4.1. Project & Clinical Trial Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Regulatory Strategy
    • 5.5.1. Regulatory Strategy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Data Management & Medical Writing
    • 5.6.1. Data Management & Medical Writing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Clinical Monitoring
    • 5.7.1. Clinical Monitoring Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.8. Quality Management / GMP Compliance
    • 5.8.1. Quality Management / GMP Compliance Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.9. Biostatistics & Safety Monitoring
    • 5.9.1. Biostatistics & Safety Monitoring Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.10. Patient & Site Recruitment
    • 5.10.1. Patient & Site Recruitment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.11. Technology Transfer
    • 5.11.1. Technology Transfer Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.12. Others
    • 5.12.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Cell & Gene Therapy Contract Research Organizations Market: Indication Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Cell & Gene Therapy Contract Research Organizations Market Indication Movement Analysis
  • 6.3. Global Cell & Gene Therapy Contract Research Organizations Market Size & Trend Analysis, by Indication, 2021 to 2033 (USD Million)
  • 6.4. Oncology
    • 6.4.1. Oncology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. CNS Disorders
    • 6.5.1. CNS Disorders Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Infectious Diseases
    • 6.6.1. Infectious Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Immunological Disorders
    • 6.7.1. Immunological Disorders Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. Cardiovascular Diseases
    • 6.8.1. Cardiovascular Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.9. Respiratory Diseases
    • 6.9.1. Respiratory Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.10. Diabetes
    • 6.10.1. Diabetes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.11. Ophthalmology
    • 6.11.1. Ophthalmology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.12. Pain Management
    • 6.12.1. Pain Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.13. Others
    • 6.13.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Cell & Gene Therapy Contract Research Organizations Market: Modality Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Cell & Gene Therapy Contract Research Organizations Market Modality Movement Analysis
  • 7.3. Global Cell & Gene Therapy Contract Research Organizations Market Size & Trend Analysis, by Modality, 2021 to 2033 (USD Million)
  • 7.4. Cell-Based Therapies
    • 7.4.1. Cell-Based Therapies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Gene Therapies
    • 7.5.1. Gene Therapies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Gene-Modified Cell Therapies
    • 7.6.1. Gene-Modified Cell Therapies Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Cell & Gene Therapy Contract Research Organizations Market: Regional Estimates & Trend Analysis by Type, Product, Test, Sample, End Use

  • 8.1. Regional Market Dashboard
  • 8.2. Global Regional Market Snapshot
  • 8.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
  • 8.4. North America
    • 8.4.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.2. U.S.
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.3. Canada
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.4. Mexico
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5. Europe
    • 8.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.2. UK
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.3. Germany
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.4. France
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.5. Italy
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Competitive Scenario
      • 8.5.5.3. Regulatory Framework
      • 8.5.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.6. Spain
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Competitive Scenario
      • 8.5.6.3. Regulatory Framework
      • 8.5.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.7. Denmark
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competitive Scenario
      • 8.5.7.3. Regulatory Framework
      • 8.5.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.8. Sweden
      • 8.5.8.1. Key Country Dynamics
      • 8.5.8.2. Competitive Scenario
      • 8.5.8.3. Regulatory Framework
      • 8.5.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.9. Norway
      • 8.5.9.1. Key Country Dynamics
      • 8.5.9.2. Competitive Scenario
      • 8.5.9.3. Regulatory Framework
      • 8.5.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.2. Japan
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.3. China
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.4. India
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Competitive Scenario
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.5. Australia
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Competitive Scenario
      • 8.6.5.3. Regulatory Framework
      • 8.6.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.6. South Korea
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Competitive Scenario
      • 8.6.6.3. Regulatory Framework
      • 8.6.6.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.7. Thailand
      • 8.6.7.1. Key Country Dynamics
      • 8.6.7.2. Competitive Scenario
      • 8.6.7.3. Regulatory Framework
      • 8.6.7.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Framework
      • 8.7.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.3. Argentina
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Framework
      • 8.7.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.8. MEA
    • 8.8.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. Key Country Dynamics
      • 8.8.2.2. Competitive Scenario
      • 8.8.2.3. Regulatory Framework
      • 8.8.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key Country Dynamics
      • 8.8.3.2. Competitive Scenario
      • 8.8.3.3. Regulatory Framework
      • 8.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.8.4. UAE
      • 8.8.4.1. Key Country Dynamics
      • 8.8.4.2. Competitive Scenario
      • 8.8.4.3. Regulatory Framework
      • 8.8.4.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.8.5. Kuwait
      • 8.8.5.1. Key Country Dynamics
      • 8.8.5.2. Competitive Scenario
      • 8.8.5.3. Regulatory Framework
      • 8.8.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Cell & Gene Therapy Contract Research Organizations Market Share Analysis, 2024
  • 9.3. Company Profiles
    • 9.3.1. Altasciences
      • 9.3.1.1. Company overview
      • 9.3.1.2. Financial performance
      • 9.3.1.3. Product benchmarking
      • 9.3.1.4. Strategic initiatives
    • 9.3.2. Allucent
      • 9.3.2.1. Company overview
      • 9.3.2.2. Financial performance
      • 9.3.2.3. Product benchmarking
      • 9.3.2.4. Strategic initiatives
    • 9.3.3. Labcorp
      • 9.3.3.1. Company overview
      • 9.3.3.2. Financial performance
      • 9.3.3.3. Product benchmarking
      • 9.3.3.4. Strategic initiatives
    • 9.3.4. Linical
      • 9.3.4.1. Company overview
      • 9.3.4.2. Financial performance
      • 9.3.4.3. Product benchmarking
      • 9.3.4.4. Strategic initiatives
    • 9.3.5. Medpace
      • 9.3.5.1. Company overview
      • 9.3.5.2. Financial performance
      • 9.3.5.3. Product benchmarking
      • 9.3.5.4. Strategic initiatives
    • 9.3.6. Thermo Fisher Scientific Inc.
      • 9.3.6.1. Company overview
      • 9.3.6.2. Financial performance
      • 9.3.6.3. Product benchmarking
      • 9.3.6.4. Strategic initiatives
    • 9.3.7. Precision Medicine Group, LLC.
      • 9.3.7.1. Company overview
      • 9.3.7.2. Financial performance
      • 9.3.7.3. Product benchmarking
      • 9.3.7.4. Strategic initiatives
    • 9.3.8. QPS Holdings
      • 9.3.8.1. Company overview
      • 9.3.8.2. Financial performance
      • 9.3.8.3. Product benchmarking
      • 9.3.8.4. Strategic initiatives
    • 9.3.9. Syneos Health
      • 9.3.9.1. Company overview
      • 9.3.9.2. Financial performance
      • 9.3.9.3. Product benchmarking
      • 9.3.9.4. Strategic initiatives
    • 9.3.10. ICON plc
      • 9.3.10.1. Company overview
      • 9.3.10.2. Financial performance
      • 9.3.10.3. Product benchmarking
      • 9.3.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by region, 2021 - 2033 (USD Million)
  • Table 3 North America Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 4 North America Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 5 North America Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Indication, 2021 - 2033 (USD Million)
  • Table 6 North America Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Modality, 2021 - 2033 (USD Million)
  • Table 7 North America Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 8 U.S. Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 9 U.S. Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 10 U.S. Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Indication, 2021 - 2033 (USD Million)
  • Table 11 U.S. Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Modality, 2021 - 2033 (USD Million)
  • Table 12 Canada Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 13 Canada Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 14 Canada Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Indication, 2021 - 2033 (USD Million)
  • Table 15 Canada Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Modality, 2021 - 2033 (USD Million)
  • Table 16 Mexico Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 17 Mexico Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 18 Mexico Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Indication, 2021 - 2033 (USD Million)
  • Table 19 Mexico Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Modality, 2021 - 2033 (USD Million)
  • Table 20 Mexico Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 21 Europe Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 22 Europe Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 23 Europe Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Indication, 2021 - 2033 (USD Million)
  • Table 24 Europe Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Modality, 2021 - 2033 (USD Million)
  • Table 25 Europe Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 26 UK Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 27 UK Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 28 UK Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Indication, 2021 - 2033 (USD Million)
  • Table 29 UK Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Modality, 2021 - 2033 (USD Million)
  • Table 30 Germany Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 31 Germany Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 32 Germany Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Indication, 2021 - 2033 (USD Million)
  • Table 33 Germany Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Modality, 2021 - 2033 (USD Million)
  • Table 34 France Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 35 France Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 36 France Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Indication, 2021 - 2033 (USD Million)
  • Table 37 France Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Modality, 2021 - 2033 (USD Million)
  • Table 38 Spain Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 39 Spain Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 40 Spain Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Indication, 2021 - 2033 (USD Million)
  • Table 41 Spain Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Modality, 2021 - 2033 (USD Million)
  • Table 42 Italy Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 43 Italy Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 44 Italy Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Indication, 2021 - 2033 (USD Million)
  • Table 45 Italy Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Modality, 2021 - 2033 (USD Million)
  • Table 46 Sweden Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 47 Sweden Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 48 Sweden Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Indication, 2021 - 2033 (USD Million)
  • Table 49 Sweden Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Modality, 2021 - 2033 (USD Million)
  • Table 50 Denmark Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 51 Denmark Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 52 Denmark Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Indication, 2021 - 2033 (USD Million)
  • Table 53 Denmark Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Modality, 2021 - 2033 (USD Million)
  • Table 54 Norway Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 55 Norway Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Phase, 2021 - 2033 (USD Million)
  • Table 56 Norway Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 57 Norway Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Indication, 2021 - 2033 (USD Million)
  • Table 58 Asia Pacific Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 59 Asia Pacific Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 60 Asia Pacific Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Indication, 2021 - 2033 (USD Million)
  • Table 61 Asia Pacific Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Modality, 2021 - 2033 (USD Million)
  • Table 62 Asia Pacific Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 63 Norway Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Modality, 2021 - 2033 (USD Million)
  • Table 64 Japan Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 65 Japan Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 66 Japan Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Indication, 2021 - 2033 (USD Million)
  • Table 67 Japan Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Modality, 2021 - 2033 (USD Million)
  • Table 68 China Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 69 China Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 70 China Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Indication, 2021 - 2033 (USD Million)
  • Table 71 China Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Modality, 2021 - 2033 (USD Million)
  • Table 72 India Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 73 India Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 74 India Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Indication, 2021 - 2033 (USD Million)
  • Table 75 India Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Modality, 2021 - 2033 (USD Million)
  • Table 76 Australia Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 77 Australia Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 78 Australia Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Indication, 2021 - 2033 (USD Million)
  • Table 79 Australia Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Modality, 2021 - 2033 (USD Million)
  • Table 80 Thailand Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 81 Thailand Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 82 Thailand Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Indication, 2021 - 2033 (USD Million)
  • Table 83 Thailand Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Modality, 2021 - 2033 (USD Million)
  • Table 84 South Korea Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 85 South Korea Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 86 South Korea Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Indication, 2021 - 2033 (USD Million)
  • Table 87 South Korea Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Modality, 2021 - 2033 (USD Million)
  • Table 88 Latin America Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 89 Latin America Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 90 Latin America Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Indication, 2021 - 2033 (USD Million)
  • Table 91 Latin America Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Modality, 2021 - 2033 (USD Million)
  • Table 92 Latin America Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 93 Brazil Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 94 Brazil Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 95 Brazil Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Indication, 2021 - 2033 (USD Million)
  • Table 96 Brazil Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Modality, 2021 - 2033 (USD Million)
  • Table 97 Argentina Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 98 Argentina Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 99 Argentina Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Indication, 2021 - 2033 (USD Million)
  • Table 100 Argentina Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Modality, 2021 - 2033 (USD Million)
  • Table 101 MEA Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 102 MEA Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 103 MEA Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Indication, 2021 - 2033 (USD Million)
  • Table 104 MEA Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Modality, 2021 - 2033 (USD Million)
  • Table 105 MEA Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 106 South Africa Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 107 South Africa Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 108 South Africa Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Indication, 2021 - 2033 (USD Million)
  • Table 109 South Africa Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Modality, 2021 - 2033 (USD Million)
  • Table 110 Saudi Arabia Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 111 Saudi Arabia Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 112 Saudi Arabia Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Indication, 2021 - 2033 (USD Million)
  • Table 113 Saudi Arabia Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Modality, 2021 - 2033 (USD Million)
  • Table 114 UAE Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 115 UAE Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 116 UAE Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Indication, 2021 - 2033 (USD Million)
  • Table 117 UAE Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Modality, 2021 - 2033 (USD Million)
  • Table 118 Kuwait Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 119 Kuwait Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 120 Kuwait Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Indication, 2021 - 2033 (USD Million)
  • Table 121 Kuwait Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, by Modality, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Cell & Gene Therapy Contract Research Organizations market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Commodity flow analysis
  • Fig. 8 Value-Chain-Based Sizing & Forecasting
  • Fig. 9 QFD model sizing & forecasting
  • Fig. 10 Bottom-up approach
  • Fig. 11 Market snapshot
  • Fig. 12 Segment snapshot
  • Fig. 13 Segment snapshot
  • Fig. 14 Segment snapshot
  • Fig. 15 Competitive landscape snapshot
  • Fig. 16 Parent market outlook, 2024 (USD Million)
  • Fig. 17 Ancillary market outlook, 2024 (USD Million)
  • Fig. 18 Cell & Gene Therapy Contract Research Organizations Market Dynamics
  • Fig. 19 Total R&D drug pipeline size, 2021 - 2024
  • Fig. 20 Total drug pipeline by development phase, 2024
  • Fig. 21 Porter's five forces analysis
  • Fig. 22 PESTEL analysis
  • Fig. 23 Cell & Gene Therapy Contract Research Organizations market Type outlook: Segment dashboard
  • Fig. 24 Cell & Gene Therapy Contract Research Organizations market, by Type segment: Market share, 2025 & 2033
  • Fig. 25 Drug Discovery market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Preclinical market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Clinical market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Target Validation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Lead Identification market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Lead Optimization market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Cell & Gene Therapy Contract Research Organizations market Phase outlook: Segment dashboard
  • Fig. 32 Cell & Gene Therapy Contract Research Organizations market, by Phase segment: Market share, 2024 & 2033
  • Fig. 33 Phase I market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Phase II market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Phase III market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Phase IV market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Cell & Gene Therapy Contract Research Organizations market Service outlook: Segment dashboard
  • Fig. 38 Cell & Gene Therapy Contract Research Organizations market, by Service segment: Market share, 2024 & 2033
  • Fig. 39 Project & Clinical Trial Management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Regulatory Strategy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Data Management & Medical Writing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Clinical Monitoring market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Quality Management / GMP Compliance market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Biostatistics & Safety Monitoring market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Patient & Site Recruitment market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Technology Transfer market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Cell & Gene Therapy Contract Research Organizations market Indication outlook: Segment dashboard
  • Fig. 49 Cell & Gene Therapy Contract Research Organizations market, by Indication segment: Market share, 2024 & 2033
  • Fig. 50 Oncology market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 CNS Disorders market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Infectious Diseases market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Immunological Disorders market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Cardiovascular Diseases market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Respiratory Diseases market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Diabetes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Ophthalmology market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Pain Management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Cell & Gene Therapy Contract Research Organizations market Modality outlook: Segment dashboard
  • Fig. 61 Cell & Gene Therapy Contract Research Organizations market, by Modality segment: Market share, 2024 & 2033
  • Fig. 62 Cell-Based Therapies market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Gene Therapies market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 Gene-Modified Cell Therapies market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Regional market: Key takeaways
  • Fig. 66 Regional marketplace: Key takeaways
  • Fig. 67 North America Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 U.S. Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 Canada Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Mexico Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 Europe Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 UK Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 Germany Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 France Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 Italy Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 Spain Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 Denmark Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 87 Key country dynamics
  • Fig. 88 Norway Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 89 Key country dynamics
  • Fig. 90 Sweden Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 91 Asia Pacific Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 92 Key country dynamics
  • Fig. 93 Japan Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 94 Key country dynamics
  • Fig. 95 China Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 96 Key country dynamics
  • Fig. 97 India Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 98 Key country dynamics
  • Fig. 99 Australia Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 100 Key country dynamics
  • Fig. 101 South Korea Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 102 Key country dynamics
  • Fig. 103 Thailand Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 104 Latin America Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 105 Key country dynamics
  • Fig. 106 Brazil Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 107 Key country dynamics
  • Fig. 108 Argentina Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 109 MEA Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 110 Key country dynamics
  • Fig. 111 South Africa Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 112 Key country dynamics
  • Fig. 113 Saudi Arabia Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 114 Key country dynamics
  • Fig. 115 Kuwait Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 116 Key country dynamics
  • Fig. 117 UAE Cell & Gene Therapy Contract Research Organizations market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 118 Market participant categorization
  • Fig. 119 Heat map analysis